{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:04:43Z","timestamp":1788383083310,"version":"build-2803163510"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The optimal management of chronic obstructive pulmonary disease (COPD) requires effective drug delivery through dry powder inhalers (DPIs). Maximum forced inspiratory flow (FIFmax), easily obtained from routine spirometry, can reflect inspiratory capacity and serve as a physiological marker associated with exacerbation risk. However, its clinical implications have not been fully established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed COPD patients treated with DPIs over a 5-year observational period. Baseline and follow-up FIFmax values were measured through repeated spirometric evaluations. The primary outcome was the incidence of moderate-to-severe exacerbations. The optimal cutoff of FIFmax for minimizing the risk of moderate-to-severe exacerbations was calculated, and the clinical factors associated with maintaining FIFmax above this optimal cutoff were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A FIFmax threshold of 220 L\/min was identified as the most optimal cutoff for lowering the risk of moderate-to-severe exacerbations. Patients who maintained FIFmax above this threshold over 5 years showed a significantly reduced risk of moderate-to-severe exacerbation (adjusted hazard ratio = 0.722 [95% confidence interval = 0.546\u20130.953],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.022). Factors such as younger age, lower comorbidity burden, and better baseline lung function were linked to a higher FIFmax. In contrast, advanced age, severe comorbidities, and poor inhaler technique were associated with a rapid decline in FIFmax.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FIFmax can be a promising physiological marker that reflects inspiratory capacity and stratifies exacerbation risk in COPD patients using DPIs. Regular assessment and patient education to maintain adequate inspiratory flow could support more effective disease management and stable long-term outcomes in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19412711251406054","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:03:36Z","timestamp":1767092616000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimal Maximal Forced Inspiratory Flow for Dry Powder Inhalers in Reducing Exacerbations in COPD"],"prefix":"10.1177","volume":"39","author":[{"given":"Kwang Yong","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heemoon","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Heo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deog Kyeom","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-0260","authenticated-orcid":false,"given":"Hyun Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2016.1297"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2012.0987"},{"issue":"3","key":"e_1_3_2_4_2","first-page":"217","article-title":"Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation","volume":"4","author":"Sharma G","year":"2017","unstructured":"Sharma G, , Mahler DA, , Mayorga VM, et al. Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chronic Obstr Pulm Dis, 2017; 4(3):217\u2013224.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S353441"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S380736"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00128113"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S291554"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201611-903OC"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.07.162"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2015.1224"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.03.049"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2024.0156"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1495867"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.23.1.33"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00035005"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s11474"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105857"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201702-156PS"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64235-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200020010-00004"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/089426802760292636"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/089426801316970268"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2017.1416"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S297980"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2012.02.003"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2006.19.329"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8502(96)00021-3"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41533-022-00318-3"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-2050-x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2017.06.005"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1200555"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020458"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134420"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000088095"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.99.1.128"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12070"},{"issue":"9","key":"e_1_3_2_40_2","first-page":"1068","article-title":"Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients","volume":"15","author":"Gatta D","year":"2011","unstructured":"Gatta D, , Aliprandi G, , Pini L, et al. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Eur Rev Med Pharmacol Sci, 2011; 15(9):1068\u20131073.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2025.40.e32"}],"container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711251406054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19412711251406054","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711251406054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:15:33Z","timestamp":1777900533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19412711251406054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,1]]}},"alternative-id":["10.1177\/19412711251406054"],"URL":"https:\/\/doi.org\/10.1177\/19412711251406054","relation":{},"ISSN":["1941-2711","1941-2703"],"issn-type":[{"value":"1941-2711","type":"print"},{"value":"1941-2703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}